POPULARITY
6 episodes with Hopa
4 episodes with Hopa
2 episodes with Hopa
3 episodes with Hopa
2 episodes with Hopa
2 episodes with Hopa
2 episodes with Hopa
2 episodes with Hopa
4 episodes with Hopa
“There have been many changes since the '70s that have shaped the nurse's role in administering chemo, and in supporting patients. The major change early on was the transition from that of nurses mixing chemo to that of pharmacists. Regulatory agencies like NIOSH and OSHA defined chemotherapy as hazardous drugs, and professional organizations became involved, leading to the publication of the joint ASCO and ONS Standards of Safe Handling,” ONS member Scarlott Mueller, MPH, RN, FAAN, secretary of the American Cancer Society Cancer Action Network Board and member of the Oncology Nursing Foundation Capital Campaign Cabinet, told Darcy Burbage, DNP, RN, AOCN®, CBCN®, ONS member and chair of the ONS 50th Anniversary Committee during a conversation about the evolution of chemotherapy treatment. Along with Mueller, Burbage spoke with John Hillson, DNP, NP, Mary Anderson, BSN, RN, OCN®, and Kathleen Shannon-Dorcy, PhD, RN, FAAN, about the changes in radiation, oral chemotherapy, and cellular therapy treatments they have witnessed during their careers. Music Credit: “Fireflies and Stardust” by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0 Episode Notes This episode is not eligible for NCPD. ONS Podcast™ episodes: 50th anniversary series Episode 330: Stay Up to Date on Safe Handling of Hazardous Drugs Episode 59: Blood and Marrow Transplant Nursing Episode 16: Navigating the Challenges of Oral Chemotherapy ONS Voice article:Safe Handling—We've Come a Long Way, Baby! ONS books: Chemotherapy and Immunotherapy Guidelines and Recommendations for Practice (second edition) Hematopoietic Stem Cell Transplantation: A Manual for Nursing Practice (third edition) Oncology Nurse Navigation: Delivering Patient-Centered Care Across the Continuum (second edition) Safe Handling of Hazardous Drugs (fourth edition) ONS courses: ONS Hematopoietic Stem Cell Transplantation™ ONS/ONCC® Chemotherapy Immunotherapy Certificate™ ONS/ONCC® Radiation Therapy Certificate™ Safe Handling Basics Oral Anticancer Medication Toolkit Oral Anticancer Medication Care Compass Patient education guides created as a collaboration between ONS, HOPA, NCODA, and the Association of Community Cancer Centers: IV Cancer Treatment Education Sheets Oral Chemotherapy Education Sheets Connie Henke Yarbro Oncology Nursing History Center To discuss the information in this episode with other oncology nurses, visit the ONS Communities. To find resources for creating an ONS Podcast Club in your chapter or nursing community, visit the ONS Podcast Library. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From This Episode Hillson: “I remember as a new grad, from back in '98, walking up to the oncology floor. We had patients with pink labels on the chart and that was the radiation oncology service. I hadn't heard of such a thing before. … I'd gone through nursing school and hospital orientation and unit orientation without ever hearing of these therapies. At the time, both the management and the union had no interest in specialist nurses, and the really weren't any books that were targeting the role. And it was very isolating and frightening. I was very glad to find ONS when I moved to the U.S. Right now, the Oncology Nursing Society Manual for Radiation Oncology, Nursing Practice, and Education, it's in its fifth edition and a sixth is underway. There's nothing else like it. Most books are very much geared towards other professions.” TS 5:34 Mueller: “We mixed our chemo in a very small medication room on the unit, under a horizontal laminar flow hood, which we later discovered should have been a vertical laminar flow hood. Initially, we did not use any personal protective equipment. I remember mixing drugs like bleomycin and getting a little spray that from the vial onto my face. And to this day, I still have a few facial blemishes from that.” TS 14:28 Anderson: “As the increasing number of these actionable mutations continue to grow, so will the number of oral anticancer medications that patients are going to be taking. And we are already seeing that there's multiple combination regimens and complex schedules that the patients have to take. So this role the oral oncolytic nurse and the nursing role, like you said, it cannot be owned by one individual or discipline. So it's not a pharmacist; the pharmacies aren't owning this. The nurses are not owning this. It takes a village.” TS 32:12 Shannon-Dorcy: Then as immunotherapy comes into the picture, we start to learn about [cytokine release syndrome]. All of a sudden, we had no concept that this was a deadly consequence. ONS was on the front lines, convening people across the country together so we could speak to the investigative work with science and find ways that we could intervene, how we can look for signs of it early on with handwriting testing.” TS 39:58
Latest Utah Avalanche Center forecast, Summit County Community Development Director Peter Barnes has an update on development projects throughout the county, Park City Chamber Bureau Sustainability Director Morgan Mingle shares details on this year's sustainability grants and executive director of Mountainlands Community Housing Trust Jason Glidden provides an update on the HOPA rebuild and other affordable housing issues.
“What I find most rewarding is connecting with nurses, who now understand the risks of exposure and are committed to minimizing their personal exposure. When I first started speaking about safe handling, there were a lot of nurses who were skeptical about the need for self-protection. I rarely see that now. Nurses are concerned for their own safety and more open to protective behaviors,” ONS member Martha Polovich, PhD, RN, AOCN®-Emeritus, adjunct professor in the School of Medicine at the University of Maryland, told Liz Rodriguez, DNP, RN, OCN®, CENP, ONS member and 50th anniversary committee member, during a conversation about the evolution of safe handling of hazardous drugs and ONS's role in shaping safe handling policies. Music Credit: “Fireflies and Stardust” by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0 Earn 0.5 contact hours of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at courses.ons.org by February 7, 2027. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. Learning outcome: Learners will report an increase in knowledge related to the evolution of safe handling guidelines. Episode Notes Complete this evaluation for free NCPD. ONS Podcast™ episodes: Episode 330: Stay Up to Date on Safe Handling of Hazardous Drugs Episode 308: Hazardous Drugs and Hazardous Waste: Personal, Patient, and Environmental Safety ONS 50th Anniversary series ONS Voice articles: Hazardous Drug Surface Contamination Prevails, Despite More Diligent PPE NIOSH Releases Its 2024 List of Hazardous Drugs USP Answers Some Difficult Questions About Hazardous Drug Safety ONS books: Chemotherapy and Immunotherapy Guidelines and Recommendations for Practice (second edition) Safe Handling of Hazardous Drugs (fourth edition) ONS courses: ONS Fundamentals of Chemotherapy and Immunotherapy Administration™ ONS/ONCC Chemotherapy Immunotherapy Certificate™ Safe Handling Basics Clinical Journal of Oncology Nursing articles: Hazardous Drug Contamination: Presence of Bathroom Contamination in an Ambulatory Cancer Center Oral Chemotherapy: An Evidence-Based Practice Change for Safe Handling of Patient Waste Huddle Card: Introduction to Safe Handling ONS Safe Handling Learning Library Joint ONS and Hematology/Oncology Pharmacy Association (HOPA) position statement: Ensuring Healthcare Worker Safety When Handling Hazardous Drugs National Institute for Occupational Safety and Health: Managing Hazardous Drug Exposures: Information for Healthcare Settings American Society of Health-System Pharmacists Guidelines on Handling Hazardous Drugs USP FAQs Connie Henke Yarbro Oncology Nursing History Center To discuss the information in this episode with other oncology nurses, visit the ONS Communities. To find resources for creating an ONS Podcast Club in your chapter or nursing community, visit the ONS Podcast Library. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From This Episode “PPE has always been recommended to reduce exposure because gloves and gowns provide physical barrier to protect against dermal absorption. But what we didn't know back then was what gloves and gowns were made of mattered. So PVC gloves were often used just because they were readily available in all our clinical settings. Gowns were rarely worn for drug administration, even though they had been recommended since early on, and many considered gowns back then as optional because the wording in the [Occupational Safety and Health Administration] guidelines said ‘recommended' and not ‘required.'” TS 3:19 “Those early chemo gloves were a bit like wearing gloves you might use to clean your oven. They were so thick and got in the way of taking care of patients or mixing drugs or administering drugs. So the biggest change, I think, is that gloves that are currently available are very thin, and they provide the necessary protection for those who are handling hazardous drugs. We now have a gloves standard that requires permeation studies to demonstrate the protective ability of the gloves before they can be labeled for use with hazardous drugs.” TS 11:56 “ONS and HOPA developed a position statement on safe handling of hazardous drugs. … This came because our two organizations were unable to support some of the other proposed guidelines from another organization. So we got together, and through our cooperation, resulted in language about the importance of safe handling, about supporting safe handling for practitioners, pharmacists, and nurses. Also, I feel really good about this—our cooperation resulted in language about protecting the rights of staff who are trying to conceive or who are pregnant or who are breastfeeding to engage in alternative duty that doesn't require them to handle hazardous drugs.” TS 17:12 “If there's no worker safety, then who's going to take care of the patients?” TS 21:52 “What I find most rewarding is connecting with nurses, who now understand the risks of exposure and are committed to minimizing their personal exposure. When I first started speaking about safe handling, and that's going back a long way, there were a lot of nurses who were skeptical about the need for self-protection. They had been handling hazardous drugs for years and had no signs of ill effects, and so they assumed that we weren't overreacting with all of the recommendations. They saw the use of precautions and PPE as a speed bump in their busy day and also thought that was unnecessary. I rarely see that now. Nurses are concerned for their own safety and more open to protective behaviors.” TS 23:50
This episode of ASTCT Talks dives into outpatient CAR T therapy, exploring logistics, challenges, and success strategies. Host Dr. Zahra Mahmoudjafari leads a panel of experts to share insights from their innovative programs. The panel features Robb Richards, Administrative Director of Cell Therapy and Transplant at Penn Medicine; Dr. Katie Gatwood, Clinical Pharmacy Specialist at Vanderbilt University Medical Center; and Dr. Taha Al-Juhaishi, Associate Director at the University of Oklahoma's Transplant and Cell Therapy Program. Topics include outpatient program structures, toxicity management, and the evolving role of cell therapies beyond hematologic malignancies. About the Host:Dr. Zahra Mahmoudjafari is a board-certified oncology pharmacist and Clinical Pharmacy Manager in Hematologic Malignancies at the University of Kansas Cancer Center. She earned her PharmD and MBA from UMKC and focuses on clinical and operational management of cell and gene therapies. Dr. Mahmoudjafari is active in HOPA, ATOPP, and ASTCT and was honored with ASTCT's Pharmacy SIG Lifetime Achievement Award and ASCO's 40 Under 40 in Cancer Award. Meet the Panel: Robb Richards has over 20 years of oncology experience, with roles spanning private practice, IT, and leadership in healthcare systems. At Penn Medicine, he oversees CAR T therapy operations, expanding services into community hospitals. He holds degrees from Drexel University and St. Joseph's University. Dr. Katie Gatwood is a Board-Certified Oncology Pharmacist at Vanderbilt University Medical Center, where she leads the PGY2 Oncology Residency Program and chairs the ASTCT Pharmacy SIG. Her expertise spans CAR T therapy, transplant conditioning, and GVHD therapies. Dr. Gatwood is an award-winning practitioner and has authored several publications on oncology pharmacy practice. Dr. Taha Al-Juhaishi is an attending physician and clinical investigator at OU Stephenson Cancer Center, Oklahoma's only NCI-designated center. He serves as associate director of the Hematopoietic Stem Cell Transplantation and Cell Therapy program and leads several clinical trials. Dr. Al-Juhaishi trained at Weill Cornell Medicine, VCU, and MD Anderson Cancer Center. Listeners will gain valuable insights into the complexities of managing outpatient CAR T therapy and strategies to enhance patient care.
⁰¹ M-Beat - Peeni Porni (Tim Reaper Mix) ⁰² Randall & Andy C - Sound Control ⁰³ DJ Snear - Pirates Anthem ⁰⁴ Lawze & Hurrian - Swing Dub ⁰⁵ Lion UK – Bumbaclaat ⁰⁶ Lawze & Hurrian - Scientist Dub ⁰⁷ DJ Dextrous & H-Pee - Hot Flame ⁰⁸ Lawze & Demus – Waterhouse ⁰⁹ Lion UK - Coca-Cola Bottle ¹⁰ Tim Reaper, Ontology & Dwarde - On Sight ¹¹ Splash – Babylon ¹² Trinity - Chapter 19 ¹³ H.M.P. - Runnin ¹⁴ Harmony - Hold It ¹⁵ Jo – R-Type ¹⁶ Lion UK – Purified ¹⁷ Hopa & Bones - So Sweet ¹⁸ Lawze & Demus – Your Love ¹⁹ Nectax & Tim Reaper - London Bridge ²⁰ Ray Keith - Terrorist (PA Mix) ²¹ Dillinja - Sovereign Melody ²² Dextrous & Rude Boy Keith - Lovable (Bow Street Runners Remix) ²³ Dextrous - Moonlight
14-19 Ağustos tarihleri arasında gerçekleşen 20. Hopa Kültür Sanat ve Doğa Festivali'ne uzanıyoruz. Beş gün süren festivalde, söyleşiler, konserler, spor müsabakaları, çocuk etkinlikleri, halk oyunları, atölyeler ve dinletiler gerçekleşti; festivali yerinden izleyip sesler topladık.
Jolynn Sessions, PharmD, CPP, BCOP, FHOPA, serves as President of the Hematology/Oncology Pharmacy Association (HOPA). She is an EXCLAIM Pharmacogenomics Pharmacist and an Oncology Clinical Pharmacist Specialist at the Western North Carolina VA Health Care System in Asheville, NC. We talk through her top three priorities for HOPA this year. You'll hear the top issues in oncology pharmacy and how HOPA is finding ways to solve them!
What I learned (or relearned?) at HOPA's 2024 Annual Conference: updates in Neuro Oncology, fedratinib toxicity, and bispecific antibodies in multiple myeloma. Also, fam-trastuzumab deruxtecan (T-DXd) garnered a site-agnostic approval for HER2 amplified solid tumors. Finally, the ALINA study, adjuvant alectinib in ALK+ NSCLC, was published in this week's NEJM.
This week on GameSpot After Dark: Jake has gotten into off-road trucking, Kurt is deep into the HOPA genre, Michael's got a love/hate relationship with Balatro, and Jean-Luc finally got around to playing Homebody.
“I think that there are certain agents that are so foundational in some diseases that they will remain. Whether they remain first-line, maybe not; maybe they'll go to second line as we see things evolve with new agents. Some of these drugs have been very effective in the diseases in which they are used to treat patients. There's a long term place in therapy for these, and I think that will still be using these,” Rowena Schwartz, PharmD, BCOP, FHOPA, known to many as “Moe,” professor of pharmacy practice at James L. Winkle College of Pharmacy at the University of Cincinnati in Ohio, told Lenise Taylor, oncology clinical specialist at ONS, during a discussion about what oncology nurses need to know about antimetabolites. This episode is part of a series about drug classes, which we'll include a link to in the episode notes. You can earn free NCPD contact hours after listening to this episode and completing the evaluation linked below. Music Credit: “Fireflies and Stardust” by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0 Earn 0.5 contact hours of nursing continuing professional development (NCPD), which may be applied to the oncology nursing practice and treatment ILNA categories, by listening to the full recording and completing an evaluation at myoutcomes.ons.org by December 1, 2025. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of NCPD by the American Nurses Credentialing Center's Commission on Accreditation. Learning outcome: The learner will report an increase in knowledge related to antimetabolites. Episode Notes Complete this evaluation for free NCPD. Oncology Nursing Podcast: Pharmacology 101 series ONS Voice oncology drug reference sheets ONS books: Chemotherapy and Immunotherapy Guidelines and Recommendations for Practice (second edition) Chemotherapy and Immunotherapy Guidelines and Recommendations for Practice ONS courses: ONS/ONCC Chemotherapy Immunotherapy Certificate Course ONS Fundamentals of Chemotherapy Immunotherapy Administration Clinical Journal of Oncology Nursing article: Chemoprevention: An Overview of Pharmacologic Agents and Nursing Considerations ONS Huddle Cards: Antimetabolites Alkylating Agents Miscellaneous Agents Patient education guides created as a collaboration between ONS, HOPA, NCODA, and the Association of Community Cancer Centers: Oral Chemotherapy Education Sheets Intravenous Cancer Treatment Education Sheets To discuss the information in this episode with other oncology nurses, visit the ONS Communities. To find resources for creating an ONS Podcast Club in your chapter or nursing community, visit the ONS Podcast Library. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From Today's Episode “Antimetabolites are relatively old agents. They are some of the oldest anti-cancer drugs that we have. They were developed to be similar to naturally occurring compounds that are important in cellular production. They are similar but not the same. So, they sometimes will bind to an enzyme important for cell proliferation. And because it binds to an enzyme, does it mean that it helps the enzyme? It may block it and that may cause cell death. And so, they've been used for a long time in oncology.” TS 1:44 “There's different classes of antimetabolites in oncology. If you think of the structure of DNA, there is purines, that's adenine and guanine, there are pyrimidines, which are things like cytosine and limonene, and then in RNA there's uracil. So, some of the antimetabolites are either purine analogues or pyrimidine analogues, meaning they look very much like the natural parts of DNA, and by being incorporated into the DNA they cause cell death. There's also a class of antimetabolites that interfere with how we use folate in the body, such as methotrexate is an obvious one, and these are called folate antagonists.” TS 2:43 “The purine analogs—and those are things like fludarabine or clofarabine—those drugs are very toxic to lymphocytes. And because they're very toxic to lymphocytes, these are drugs that we use in lymphocytic diseases. But that also means that these are drugs that we get immunosuppression because of the toxicity to lymphocytes. So, these patients have risk of infections because of their decreased lymphocyte activity after receiving these drugs.” TS 6:37 “Methotrexate works by blocking an enzyme that decreases the ability to make the folate that we need in our body to make cells. So, one of the things that we do when we use really high doses of methotrexate is we let it work for 24 hours and then we come in and we give leucovorin, which is the thing that we blocked. So, you're coming into rescue cells. And you're rescuing cells because the cancers we use high-dose methotrexate, we know that 24-hour exposure is going to be a really good effect on those cancer cells. So that's why we use leucovorin after methotrexate. We use it to minimize the toxicities that you would see with methotrexate. You decrease GI mucositis; you decrease the bone marrow suppression when you come in and adequately rescue with leucovorin.” TS 12:22 “I think [that's] one of the biggest challenges. I just had a situation that was an antimetabolites drug I'd never used before. I couldn't find in the literature and through resources I normally use, how to manage, so I actually reached out to colleagues to find out, who have used the medications to say, ‘What's your experience? What's worked for you?' It's one of the reasons I really love ONS, because I think it gives a forum for people to ask those questions together.” TS 15:23 “I think developing good patient education tools that people can take home that highlight the most important things about the regimen, including the antimetabolite aspects, making sure patients know what to monitor for so that they can contact their team if they need them. Diarrhea is something I always talk about with patients getting 5-fluorouracil. I do it because otherwise people self-manage and don't actually know what to do, and we really want to make sure that they contact us if they're having problems with diarrhea.” TS 17:14 “I think one of the best things that people can do is work together in the development of the order sets, whether they be electronic or not. And, so, that within the order sets there is clear indications of those things that highlight to patients the strategies to take, to manage. I think that's really helpful, and I think it's best done by a team. And to modify those order sets as things are learned that are helpful so that, you know, the strategy is dose reduction that's clear that that's going to be the strategy. So, I think that in this day and age it's really important that there is collaboration in developing whatever resources that we have.” TS 18:55 “Because gemcitabine is such a good radio sensitizer, when we use it with radiation, we use a very small dose. Very small. We're not talking anything near what we use when we use it in combination chemotherapy. So, when you have a patient getting gemcitabine, if somebody decides that they're going to do radiation, you have to make sure everybody knows they're on gemcitabine because you may hold the drug while they're getting radiation because you don't want to increase in toxicity.” TS 22:31 “I think that there are so many new, exciting agents and there are so many older agents that are still used in practice, that it's becoming very difficult for people to understand the mechanisms of the drugs that we're using and the agent-specific toxicities. So, I think that the education that's needed is the foundation and fundamentals of chemotherapy, because they still are used so much in practice. And I would hate to lose the knowledge that practitioners have because we're excited about the new, exciting therapies that are new and exciting.” TS 25:09
“When I meet with patients, I try and remind them, ‘Yes, you do have these side effects that can happen' and make sure that they're informed, but also try and reassure them that not everyone gets it as severe as maybe the movies and TV shows portray,” Dane Fritzsche, PharmD, BCOP, informatics pharmacist from the Fred Hutchinson Cancer Center at the University of Washington Medicine in Seattle, told Jaime Weimer, MSN, RN, AGCNS-BS, AOCNS®, manager of oncology nursing practice at ONS, during a discussion about what oncology nurses need to know about alkylating agents for patients with cancer. This episode is the first in a series about drug classes, which we'll include a link to in the episode notes. You can earn free NCPD contact hours after listening to this episode and completing the evaluation linked below. Music Credit: “Fireflies and Stardust” by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0 Earn 0.75 contact hours of nursing continuing professional development (NCPD), which may be applied to the oncology nursing practice and treatment ILNA categories, by listening to the full recording and completing an evaluation at myoutcomes.ons.org by November 17, 2025. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of NCPD by the American Nurses Credentialing Center's Commission on Accreditation. Learning outcome: The learner will report an increase in knowledge related to alkylating agents. Episode Notes Complete this evaluation for free NCPD. Oncology Nursing Podcast Episode 242: Oncology Pharmacology 2023: Today's Treatments and Tomorrow's Breakthroughs ONS Voice oncology drug reference sheets Clinical Journal of Oncology Nursing article: Chemoprevention: An Overview of Pharmacologic Agents and Nursing Considerations ONS book: Chemotherapy and Immunotherapy Guidelines and Recommendations for Practice (second edition) ONS Huddle Card: Alkylating Agents The Emperor of All Maladies: A Biography of Cancer by Siddhartha Mukherjee ChemoCare drug information Hematology/Oncology Pharmacy Association (HOPA) National Cancer Institute's A to Z List of Cancer Drugs Patient education guides created as a collaboration between ONS, HOPA, NCODA, and the Association of Community Cancer Centers: Oral Chemotherapy Education Sheets IV Cancer Treatment Education Sheets To discuss the information in this episode with other oncology nurses, visit the ONS Communities. To find resources for creating an ONS Podcast Club in your chapter or nursing community, visit the ONS Podcast Library. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From Today's Episode “Alkylating agents are a very interesting class of chemotherapy agents, both mechanistically as well as historically. I remember back in pharmacy school learning this was actually the first class of medicines used to treat cancer, and it actually starts way back in World War I with the use of sulfur mustard gas, in kind of a military fashion, and then noticing some of the responses that soldiers as well as civilians who were actually exposed to that. They would develop things like bone marrow suppression, as well as other antitumor effects. Sadly, it's rough to see mustard gas as being the first agent to lead to something so remarkable, because it was a weapon of devastation, but it did lead to some breakthroughs.” TS 1:43 “The first thing that jumps to my mind when thinking about alkylating agents is their toxicities and then their supportive care agents that we use to make sure that we're treating our patients well and making their care optimum. So, when I, as an oncology pharmacist, would look at these orders, I immediately am jumping to, are we giving them appropriate antiemetics? Because a lot of these agents are highly emetogenic or moderately emetogenic by NCCN. A lot of them have other organ toxicities, like are really harsh on the kidneys. Are they getting their pre- and post-hydration? And then also many of these agents are very bone marrow suppressing, meaning they're targeting the red blood cells, they're hitting platelets, they're reducing our ANCs and making patients at higher risk for infection, you know, so do we need growth factor support here? Are the patients—their current labs—are they able to take another dose at this time or do we need to dose reduce or delay therapy because their platelets are just too low now?” TS 09:54 “Honestly, it's probably one of the most important things is collaborating together to help provide optimal patient care. And to me, kind of the biggest thing that jumps out is just good communication between the various team members. I can't tell you how many times I would learn crucial information either from an infusion nurse chatting with the patient or walking down the hall or giving a call to one of our lovely clinical nurse coordinators here at Fred Hutch. You know, I always wanted to make sure that I go in and have the full picture of where the patient's at, what, if any, challenges there have been with this patient's particular case, just to make sure that I'm up to date about them and able to provide as good of care as I can.” TS 14:55 “Unfortunately, this class of drugs does come with kind of those generic chemotherapy side effects that we think of: hair loss, nausea and vomiting, and bone marrow suppression. That just comes as a function of how these work. These agents are not selective for just cancer. They're more selective for rapidly dividing cells. So, that leaves our normal cells that rapidly divide like our hair, our GI tract, our bone marrow, you know, to get hit by these.” TS 17:50 “The next thing I always drill my residents on, when I'm teaching them how to provide actionable and helpful information about their regimens that they're getting, is kind of like you're saying, outlining those expectations. How do you prevent these side effects? When do these side effects even start to show up? Like, am I going to immediately be nauseous right when the cisplatin gets turned on? Well, maybe, not super common, but it's more common that we'll see it in, you know, at the end, in the next couple of days and within the next 72 hours or going into the nuances between acute versus chronic nausea and things like that. So, it's really trying to empower the patients with information. How do they prevent this? What are we doing to help prevent it? And then when should they call us? When is the stuff that we're preventing didn't help? When should they call us to get more help?” TS 24:04 “I think that's a misconception that we as healthcare professionals can really help alleviate with our patients, reminding them that, yes, they do carry risks, but we also have a lot of supportive care agents to kind of help minimize that toxicity. And then we have this whole team of professionals behind you to help carry you through the treatment.” TS 29:34
LeAnne Kennedy, PharmD, BCOP, CPP, FHOPA, is the President of the Hematology/Oncology Pharmacy Association (HOPA), co-founder of the North Carolina Oncology Pharmacists (NCOP) Association, and Clinical Oncology Pharmacy Manager at Atrium Health Wake Forest Baptist. Dr. Kennedy talks through how NCOP started more than 20 years ago as well as her priorities for HOPA this year!
Queen Zabel of Armenia is a little-known, often-forgotten reigning queen due to her short life and the lack of information on her. However, in her short life, she became a very successful first queen of the Armenian crusader state but also suffered much tragedy as a child queen in a world of complex crusade politics. Join me to learn about Zabel's complicated life. Bibliography Alvarez, Sandra. “The Crusaders through Armenian Eyes.” Medievalists.net, July 12, 2011. https://www.medievalists.net/2011/07/the-crusaders-through-armenian-eyes/. Encyclopedia Britannica. “Armenia,” July 26, 1999. https://www.britannica.com/place/Armenia/The-marzpans. Avetisyan, Vigen. “The Traditional Armenian Wedding Dress.” Art-A-Tsolum, July 9, 2020. https://allinnet.info/culture/the-traditional-armenian-wedding-dress/. Bloks, Moniek. “Queens Regnant - Isabella, Queen of Armenia.” History of Royal Women, February 15, 2019. https://www.historyofroyalwomen.com/the-queens-regnant-series/queens-regnant-isabella-queen-of-armenia/. Contributors to Wikimedia projects. “Armenian Kingdom of Cilicia.” Wikipedia, December 9, 2022. https://en.wikipedia.org/wiki/Armenian_Kingdom_of_Cilicia. ———. “Hethum I of Armenia.” Wikipedia, June 13, 2022. https://en.wikipedia.org/wiki/Hethum_I_of_Armenia. ———. “Isabella, Queen of Armenia.” Wikipedia, August 7, 2022. https://en.wikipedia.org/wiki/Isabella,_Queen_of_Armenia. ———. “Leo I, King of Armenia.” Wikipedia, October 8, 2022. https://en.wikipedia.org/wiki/Leo_I,_King_of_Armenia. ———. “Leo II, King of Armenia.” Wikipedia, June 12, 2022. https://en.wikipedia.org/wiki/Leo_II,_King_of_Armenia. ———. “Philip of Antioch.” Wikipedia, March 15, 2022. https://en.wikipedia.org/wiki/Philip_of_Antioch. ———. “Rubenids.” Wikipedia, February 15, 2022. https://en.wikipedia.org/wiki/Rubenids. ———. “Sibylla of Cyprus.” Wikipedia, December 20, 2022. https://en.wikipedia.org/wiki/Sibylla_of_Cyprus. ———. “Stephanie of Armenia.” Wikipedia, January 19, 2022. https://en.wikipedia.org/wiki/Stephanie_of_Armenia. Smithsonian Folklife Festival. “Hopa! Rituals and Symbols of an Armenian Wedding.” Accessed December 28, 2022. https://festival.si.edu/blog/rituals-symbols-armenian-wedding-celebration.
- Le diamant Hopa - Avec Idéalvoyance.fr, la référence de la voyance, des arts divinatoires et du coaching de vie par téléphone, chat et email.
Editör: Egemen Gök AKP Genel Başkanı ve Cumhurbaşkanı Erdoğan, asgari ücrete yapılan zammı açıkladı. Buna göre yeni asgari ücret net 5 bin 500 TL oldu. Altılı masanın beşinci toplantısı pazar günü İYİ Parti'nin ev sahipliğinde yapılacak. Daha önce hep akşam yemeğinde bir araya gelen liderlerinin bu defa saat 14:00'te buluşması planlanıyor. Türkçe yayın yapan Amerika'nın Sesi ve DW Türkçe'nin internet sitelerine erişim engeli getirildi. Radyo ve Televizyon Üst Kurulu, bu iki kurumun şubat ayında lisans başvurusu yapmasını istemiş ancak kurumlar başvuruda bulunmamıştı. Artvin'in Kemalpaşa ile Hopa ilçeleri arasında heyelan meydana geldi, bir kişi hayatını kaybetti, 1 kişi ise yaralandı. Hopa'nın Esenkıyı Köyü Muhtarı Yaşar Papila, yaşanan heyelanla ilgili son durumu Medyascope'a anlattı. Gökçe Çiçek Kösedağı'nın sunduğu “Güne Bakış”ta, Işık Üniversitesi'nde çalışmalarına devam eden konuğu Dr. Onur Alp Yılmaz ile altılı masayı ve muhalefeti konuşacağız. Yayını izleyebilirsiniz: bit.ly/3nA07nf
Heidi Finnes, PharmD, BCOP, FHOPA, is the President of the Hematology/Oncology Pharmacy Association (HOPA) and Senior Manager of Pharmacy Cancer Research at the Mayo Clinic. Dr. Finnes details her goals for HOPA this year, including DEI and burnout. We also discuss investigational drugs and clinical trials!
Open up your Yelp app and check out Leukemia Pharmacist & Boston denizen Jessie Signorelli's recommendations for eating, drinking, & sight seeing in Boston. Also, great educational programming awaits!
#52 Mediteren voor groentjes! Minder stress, angst, pijn…. Betere focus, geheugen, lekker slapen… Verbeterd immuunsysteem… Noem maar op! Kan jij allemaal! Al vanaf 2 min. Per dag! Hopa! Luister deze podcast en je kunt vandaag nog starten! Enjoy Liefs jacq ❤️ https://www.myimperium.nl/
Larry Buie, PharmD, BCOP, FASHP, is the current President of the Hematology/Oncology Pharmacy Association (HOPA) and the Manager for Clinical Pharmacy Practice and PGY2 Residency Program Director at Memorial Sloane Kettering Cancer Center.Dr. Buie and Dr. Amerine talk through burnout in clinicians, Larry's transition from clinician to leader, how he manages his clinical team, and how he's changed his precepting style over the years. He'll discuss HOPA's strategic priorities over the next year and the task forces created to achieve the priorities. As we celebrate Pride month, hear Larry's thoughts on how we make our organizations and spaces around us more inclusive.
“Technology moves too quickly not to use it.” - Julianne Darling. Oral chemotherapy is one type of medically advancing technology saving lives around the world. In this episode of Working in Oncology, I take a closer look at it with Julianne Darling, Manager of Clinical Initiatives at NCODA - National Community Oncology Dispensing Association. What we talked about: - Julianne’s background - Oral chemotherapy treatments - Resources for providers and patients - Managing provider and patient education during COVID-19 - Advice for improving patient communications Check out these resources we mentioned during the podcast: - Julianne’s LinkedIn profile - Julianne’s email address - NCODA’s website - BioPlus’ website - NCODA Positive Quality Interventions - Oral Chemo Ed Sheets (website) - HOPA’s website - ONS’ website - ASCO’s website Stay connected with Working in Oncology on Apple Podcasts, Spotify, or our podcast website. Listening on a desktop & can’t see the links? Just search for Working in Oncology in your favorite podcast player.
Bilge Sayıcı ile Karşı Hukuk'un özel programında Av. Meriç Eyüboğlu ve Ulaş Lokumcu'yla 2011'de Recep Tayyip Erdoğan'ın Hopa mitingi öncesindeki protestolarda polisin sıktığı biber gazı ile yaşamını yitiren emekli öğretmen Metin Lokumcu'nun davasını konuştuk Karşı Hukuk her Çarşamba 20.30'da Mukavemet TV'de Yayınlarımızı takip etmek için: Kanalımıza abone olunuz. Sözümüzü takip etmek için: https://www.mukavemet.org/ Destekleriniz için: https://fongogo.com/Project/Sub/mukavemeti-buyutelim-2
The Bill Kelly Show Podcast Part 2: A 3-hour special featuring Mohawk College & partners Our partners were involved from the very beginning of this program. Partners like HOPA (the first employer to partner with Mohawk, before City School was even launched) offered feedback and guidance that shaped the way City School was first designed. And we have continued that level of strong collaboration ever since, through our Employer Engagement Strategy, supported by the Government of Ontario. GUEST: Emily Paivalainen, Communications and Community Relations Coordinator with the Hamilton Oshawa Port Authority - The City School model works in commercial and industrial sectors as well. Walters has been a longstanding partner with City School, guiding training and engaging with students during the training process GUEST: Natalia Strelbytsky, VP People and Culture with Walters Inc - Partnership with City School takes many forms. Through the Employer Engagement Strategy some employers provided feedback to surveys and market research responses. Others help to shape curriculum. Some are engaged in placements and employment. - In the case of FORA, a previous experience with City School resulted in involvement as a host site for City School’s second mobile classroom GUEST: Marty Verhey, Owner of FORA Outdoor Living - City School training creates opportunity for entry level employment and provides a free college credit for people who complete the course, providing a pathway to more education and a certification GUEST: Nicole Guerriero, Director of Education, Literacy and Math Academy with Lama GUEST: Yasmine Nzeba, Staff member with Lama - There is a huge demand for workers in the food processing sector. The partnership with FPSC is an example of City School’s ability to work with partners to quickly address an employment/industry need GUEST: Deanna Zenger, Project Manager of “Succeeding at Work” with Food Processing Skills Canada - We have research that demonstrates the success of City School: to reconnecting people with post-secondary training to providing skills training that leads to direct employment to helping employers quickly fill skilled and unskilled workforce gaps to offering a measurable return on investment (Deloitte reports) - This model isn’t unique to any one sector, or any one region. City School is nimble and scalable and can be deployed in other communities across the country where there is a labour shortage or a skills gap that needs to be addressed. - The pandemic recovery is going to define new jobs and emerging sectors – it will be a green resilient recovery and City School is prepared to engage with employers and all levels of government to help people return to meaningful work, for the benefit of people, of employers and of the entire community. GUEST: Ron McKerlie, President of Mohawk College GUEST: Jim Vanderveken, Dean Centre for Community and Experiential Learning at Mohawk College See omnystudio.com/listener for privacy information.
Hop je prav nenavadna stvar. Kadar je deklici, ki živi skupaj z mamo, dolgčas, skoči do neba, skoraj do sonca, in že se ji pridruži. In kaj se zgodi, ko deklico in njenega Hopa opazi poslovnež s kačico zvijačico v aktovki? Tega ne izdamo. Dramaturg je bil Ervin Fritz, režiserka Rosanda Sajko, tonska mojstrica Metka Rojc, skladatelj pa dr. Urban Koder. Deklico je igrala Kaja Desković - Živković, Hopa Janez Hočevar, Poslovneža Dare Valič, Kačico zvijačico Alja Tkačev, Mamo Majda Potokar, Vratarja Marjan Hlastec, Strokovnjaka Janez Albreht in Reklamo Jana Osojnik. Drugi igralci so bili Lenča Ferenčak, Slavko Cerjak, Srečo Špik in Judita Hahn. Igra traja 31 minut in 56 sekund. Uredništvo igranega programa. Posneta je bila v studiih Radia Ljubljana oktobra 1983.
HOPA Now is the official podcast of the Hematology/Oncology/Pharmacy Association, an organization dedicated to supporting pharmacy practitioners and promoting the advancement of Hematology/Oncology/Pharmacy to optimize the care of individuals impacted by cancer. In this episode of HOPA Now, HOPA president Dr. David DeReemer moderates a discussion on the current landscape of pancreatic cancer care, treatment, and research. Dr. DeReemer is joined by CEO and President of PanCAN, Julie Fleshman; FORD model and pancreatic cancer advocate Maria Montgomery; and Dr. Thom George, a Professor of Medicine and director of the GI Oncology Program at the University of Florida and Director of the Cancer Center Experimental Therapeutics Incubator and Associate Director of Clinical Research. They discuss ongoing initiatives and current volunteer and advocacy opportunities of PanCAN, the future of pancreatic cancer treatment and research, and the exciting work that is happening with PanCAN’s Precision Promise trial. In this episode, you will learn: Ongoing initiatives of PanCAN ● Fund research including peer-reviewed grants and large research initiatives ● Advocating in Washington D.C. for increased federal research funds ● Patient services including information that is available through a call center and email ● Building a community of volunteers, patients, families, researchers, and stakeholders ● Telehealth has received increased support and provides quality care during the COVID-19 pandemic. ● Virtual advocacy has been widely successful and effective during the pandemic. ● Volunteer activity for fundraising is supported by passionate people who have been touched by pancreatic cancer. A story of patient treatment, care, and advocacy ● Maria shares the story of her dad’s pancreatic cancer journey ● A look at common challenges in care, including a physical and emotional support system ● The silver linings that come with caring and advocating for a pancreatic cancer patient ● Go Fund Me information for Maria’s pancreatic cancer journey documentary ● The number one change Maria would like to see in cancer prevention Looking to the future of pancreatic cancer care ● Details on immunotherapeutic strategies such as ICI in combos and CAR-T ● Possible reasons that early treatment approaches have been unsuccessful ● A combination approach including chemotherapy and stimulating the immune system will offer the most promising future for pancreatic cancer care. PanCAN’s Precision Promise trial ● This Clinical research trial platform allows for testing different treatments at the same time. ● The platform is FDA-registration-enabled, allowing questions to be asked and answered that could lead to practice changes that would be FDA approved. ● The adaptive part is the most innovative program with a learn-as-you-go approach to offering treatments to patients as they are showing promise. ● Current national enrollment information ● Key inclusion and exclusion criteria of the study patient population Mentioned in This Episode: HOPA PanCAN Pancreatic Cancer Documentary (by Maria Montgomery) Go Fund Me Tweetables: “Our goal at PanCAN is to take bold action by improving the lives of everyone impacted by pancreatic cancer.” — Julie Fleshman “Although there are sad stories there are also so many positive stories about how we connect to each other. So many good people are touched by this disease.” — Julie Fleshman “The challenges of caring for a pancreatic cancer patient were more than I’d ever realized but watching people come together and support you during that time is the silver lining.” — Maria Montgomery “Early treatments we have tried haven’t worked because the cancer has gotten a head start.” — Thom George “At the end of the day, we all just want to save lives and make people’s lives better.” — Julie Fleshman
HOPA Now is the official podcast of the Hematology/Oncology/Pharmacy Association, an organization dedicated to supporting pharmacy practitioners and promoting the advancement of Hematology/Oncology/Pharmacy to optimize the care of individuals impacted by cancer. In this episode of HOPA Now, HOPA board of directors and oncology residency director Dr. Leanne Kennedy moderates a discussion on how to survive the first 60 days of an oncology pharmacy residency. Dr. Kennedy is joined by recent oncology graduates Lauren Curry and Jessica Lewis-Gonzalez to answer the FAQs of new residents regarding best practices for surviving both the first 60 days of residency. They offer advice that will help residency students best succeed, including tips to help avoid feeling overwhelmed, tools to help stay organized, and ideas for tackling research projects. They cover the key topics that will lead to successful rotations, how to determine what you want to be when you grow up, and ways to avoid burnout and get through the hardest days that are guaranteed to come. They conclude with final encouraging words of wisdom and each share whether or not they would do it all over again. In this episode, you will learn: How to avoid feeling overwhelmed Recognize that it’s okay to feel overwhelmed. Take the time to look up information that you are less comfortable with. Acknowledge that starting in PGY2 is like starting all over again — everything will feel new and that’s okay. Keep your information and notes organized by using tools such as a color-coding system, the Outlook calendar, and the OneDrive app. Create a weekly to-do list that breaks down tasks and the steps to their completion. Key journals that can help new residents stay informed Medical Facebook, Twitter, and Instagram accounts worth following Apps and podcasts that will help you stay up-to-date on the latest research How to tackle your research project and key topics for successful rotations Get an early head start to avoid last-minute scrambling. Craft a well-designed research question and research team. Plan out smaller weekly due dates to keep yourself on track. Work your personal due dates further in advance so that you can collaborate effectively. Focus on broader topics first, such as antimicrobial prophylaxis, chemotherapy-induced nausea and vomiting, and growth factors. Oncologic emergencies are among the topics that you need to master in the first 60 days as a PGY2. Is it possible to figure out what you want to study in the first 60 days? Topics from PGY1 may offer some potential topics to help structure rotations. Pursue the topics you’re interested in early on to either solidify the interest or eliminate it. Determine what you want to study before December to best prepare for PPS interviews. Preventing burnout and getting through the hardest days Take time for yourself no matter how full your schedule is, even if it's just a few minutes a few times a week to eliminate built-up stress by exercising. Read books that are not oncology-related for ‘me time.’ Recognize that the to-do list will still be there after you take a quick break. Pace yourself throughout the year so that you’re not rushing to hit deadlines. Schedule time to re-energize yourself when necessary. Talk to colleagues about lost patients to gain closure as a team and lean on your mentors to help you through the hardest times. Remember how worthwhile the work that you’re doing is despite the lowest lows. Opportunities for organization involvement Practice clinical writing by contributing to organizational newsletters. Look for mentorship programs that you can participate in. Volunteer programs can help expand your network. Mentioned in This Episode: HOPA ASTCT Blood HemOnc Today ASH ASCO Oncology Times Prime Oncology NCCN Ash Pocket Guides App OncoPharm Podcast Plenary Session Podcast Quotes: “It’s okay to take a moment to look things up, look things up and dig deeper into the literature.” — Jessica Lewis-Gonzalez “Getting started on projects as soon as possible is important. Even though you have a year, a lot can come up in that year.” — Lauren Curry “There are topics that you might have had a little exposure to in PGY1, but not to the depth that you need to understand it as a PGY2.” — Jessica Lewis-Gonzalez “Remember that the work you’re doing is so worthwhile and that there are so many good moments there.” — Lauren Curry “Stay organized. Pacing yourself throughout the year is going to be your best friend.” — Jessica Lewis-Gonzalez
Rona Hartner a traditional dancer, singer and actress, known for her celebration of Balkan culture. Her work, whether on the screen, or on the dance floor, is as full of life as she is. Olivia Cummings, founder of jewellery brand Cleopatra's Bling, talks to Rona about her role in the 1997 film Gadjo Dilo starring alongside French film star Romain Duris. She sang a ballad called "You're More Than That" for the film, which she later re-recorded with Director David Lynch. Olivia and Rona discuss what how she translates dance into life and back again, her role in Gadjo Dilo and the meaning of HOPA! Cleopatra's Bling Podcast was produced by Studio Ochenta, a Paris-based podcast studio dedicated to raising voices across cultures through international podcasts. Original music by Cameron Alva.
A plethora of #oncopharm updates! Isatuximab is approved and neratinib gets another breast cancer indication (2:00) Pembrolizumab with chemo for triple-negative breast cancer (8:50) New EPOC updated survival analysis on FOLFOX+cetuximab in isolated liver metastatic colon cancer (15:00) Precision medicine in pancreatic cancer (19:30) Cladribine + rituximab for hairy cell leukemia (23:30)
HOPA Now is the official podcast of the Hematology/Oncology/Pharmacy Association (HOPA). HOPA is an organization dedicated to supporting pharmacy practitioners and promoting the advancement of Hematology/Oncology/Pharmacy to optimize the care of individuals impacted by cancer. In this inaugural episode of HOPA Now, At-Large Board Member Jeremy Whalen interviews Larry Buie, At-Large Board Member, and Ryan Bookout, Immediate Past President. They will be discussing the 16th annual HOPA Ahead 2020 Conference highlights and the value of attending. Scheduled for March 11–14th in Tampa, Florida, HOPA Ahead is the must-attend event for pharmacists, pharmacy researchers, administrators, technicians, residents, and interns specializing in hematology-oncology. In this episode you will learn: How attendees can best prepare for the conference ● Download the HOPA conference app — the link will be emailed out two weeks prior to the conference. ● Build a schedule on the app to view poster abstracts, electronic posters and to prioritize key sessions. ● Conference highlights include two pre-conference sessions focusing on geriatrics and leadership and keynote speaker Leigh Boehmer. After-hour recommendations for the Tampa Bay area ● The conference hotel is centrally located in downtown Tampa with access to Harbor Island, the Channelside District, and Hyde Park. ● For outdoor dining and bowling, visit Sparksman’s Wharf. ● For some great drink options, consider Meridien Hotel, Hotel Bar, and GenX Tavern. ● For award-winning dining and shopping, visit Armature Works, Hyde Park Village, Bern’s Steakhouse, Tampa Heights, and International Plaza Mall. ● For live entertainment, visit Straz Center or Ybor City. ● Several running trails are accessible from the conference hotel. Additional conference offerings ● Attendees can receive up to an additional 20.25 ACPE credits by attending conference sessions. ● Book club discussions will center around The Making of a Manager. ● Networking and professional development opportunities will be readily available at the conference, including HOPA Gives Back volunteer event, leadership roundtables, and the student, resident, fellow, and new practitioner networking event. ● Nine different oncology events will take place over two days. ● “HOPA Cabana” is the Friday night reception that you won’t want to miss. Mentioned in This Episode: HOPA’s 16th Annual Conference Leigh Boehmer Sparkman Wharf Le Méridien Hotel Hotel Bar GenX Tavern Armature Works Hyde Park Village Bern’s Steakhouse The Making of a Manager: What To Do When Everyone Looks To You, by Julie Zhuo International Plaza Mall Straz Center Ybor City
The podcast miniseries is back this week with an oncology pharmacy society! The International Society of Oncology Pharmacy Practitioners is featured today: https://www.isopp.org/. ISOPP, "exists to advance oncology pharmacy care for patients around the world." Our guest today is Dr. Lisa M. Holle, PharmD, BCOP, FHOPA, FISOPP - the current Treasurer of ISOPP. Biosketch on Dr. Holle: Dr. Holle completed her Bachelor of Science in Pharmacy and post-baccalaureate Doctor of Pharmacy from the University of Wisconsin–Madison. She completed a specialized oncology residency at UT M.D. Anderson Cancer Center, and is a board-certified oncology pharmacist. Dr. Holle has worked as an oncology pharmacist for over 20 years in a variety of settings including private hospitals, academic medical centers, and medical communications. Currently, Dr. Holle is an Associate Clinical Professor at the UConn School of Pharmacy and Associate Professor at the UConn School of Medicine. Her practice site is at the UConn Health Carole and Ray Neag Comprehensive Cancer Center, where she works in a team-based ambulatory care clinic focusing on genitourinary and gastrointestinal cancers and in another team based-clinic focusing on hematologic malignancies. Dr. Holle is a Past President of HOPA and current Treasurer of the International Society of Oncology Pharmacy Practitioners (ISOPP). She is also an active member in many other professional oncology and pharmacy organizations. Dr. Holle’s clinical research program focuses on numeracy and patient decision-making, oncology quality improvement initiatives, medical marijuana, and oral anticancer therapy management. She has authored numerous articles and chapters on oncology and teaching-related topics. Dr. Holle was named an ISOPP Fellow in 2019. ISOPP on Facebook: https://www.facebook.com/ISOPP-International-Society-of-Oncology-Pharmacy-Practitioners-225135194163335/ On LinkedIn: https://www.linkedin.com/groups/4552256/
Kenge te zgjedhura nga un Xhelil Gashi
Abdullah ve Özcan; 1. Lig, 2. Lig ve 3.Lig'i tüm detaylarıyla konuşmaya tam gaz devam ediyor. Alt liglerin yegâne podcasti, kağıt biletlerin döndüğü günün umuduyla sizlerle! --- Support this podcast: https://anchor.fm/bosyapma/support
In this episode of Africa State of Mind, we get a chance to speak to Lawyer and Activist turned Model Thando Hopa. Hopa shares some of her life challenges and how she overcame the struggle of living with albinism and reimagining what identity is.
Kazım Kızıl bir belgeselci, fotoğrafçı ve işine tutkuyla bağlı bir insan. Bir bakıyorsunuz Hopa’da sel felaketinde köylere yardım götüren insanları çekiyor, bir bakıyorsunuz Soma’da madenci yakınlarının yanında. Ya da bir bakıyorsunuz Yırca’da kesilen zeytin ağaçlarını videoya çekip belgeliyor. Kazım'la tüm bu süreçte başına gelenleri konuştuk. Müzik: Evgeny Grinko Short Memory, Where Art Thou
The cover of this month’s Vogue Portugal edition featured a model, like it usually does.But this one is groundbreaking. The issue is about the diversity of African beauty, and it is the first Vogue cover to feature a woman with albinism. Her name is Thando Hopa and she’s a lawyer and activist from South Africa.The world has reacted to seeing Hopa on the cover. "That was so exciting," says Brandi Marie, a social worker and black woman with albinism from Chicago. "I got really emotional because growing up, I didn’t see myself. I looked through these magazines wanting to see myself represented — and I never did."Hopa says that her parents actually taught her that she was "beautiful all the time." It was outside her parents' home that she felt unaccepted by society. "When I grew up, I grew up having parents who were absolutely wonderful, who taught me that I was beautiful all the time, but then when I went into society and I looked at the media space, I wasn't represented with respect to what was portrayed as beautiful," Hopa told The World's Marco Werman. "I started developing inadequacy, as I had a relationship with society that took quite awhile for me to understand beauty in terms of me just being me and accepting that my eyebrows are pale, my eyelashes are pale, that my hair is curly and blonde as opposed to curly and black." Thando Hopa: I had to cultivate a sense of enoughness that freed me from the validation of society and what it considered beauty to be. I had to go into the modeling industry understanding what the media space was saying was beautiful. My purpose was to focus on representation and saying that the way I look is enough whether I am on a Vogue cover or not. I needed to cultivate that sense within myself in order for me to free myself from the societal norms. To be quite honest, when I saw myself on a Vogue cover, I felt more relief than happiness. Relief in that I had gone through so many battles, and a lot of the times when you're going through all of these nuanced battles with respect to representation, when you actually get there, more than anything you just feel relief that you know what you've managed to do.Marco Werman: I know you've probably told this story many times by now, but maybe one more time you could share it with us. How did you go from lawyer and activist to being a model?I was a prosecutor and I used to prosecute in sexual offense cases. I decided to take a sabbatical, but I had already started my modeling career at the time. I went into it as a platform of representation.So, modeling is activism for you? How did the modeling industry respond to a woman with albinism who is also an activist for albinism?I think when I started off in the industry, I was still trying to cultivate my own self-worth with respect to the industry. I started experiencing a great deal of boxing and stereotyping. It was a constant narrative of prejudice in Africa. It wasn't that the narrative was not significant or important; it's that it became an all-consuming narrative and it started chipping away at my complete humanity in that I had experiences that people just did not consider important anymore. I was only the story.Related: Congo: Albino rapper N'Kashh prepares his debut albumDid you ever think that maybe modeling isn't the way to do this kind of activism?To be quite honest with you, I think it was one of the best ways because media was a negotiating medium. It helped negotiate a new narrative with respect to many things and albinism was one of them. I started learning how to harness a more complete identity with respect to how people see albinism using media through the modeling space.How did this Vogue cover come about?I received an email from Portugal. They said that there was a cover opportunity photo shoot and I said "a cover?" I didn't believe it, to be honest. I went to my mother and I said to her that I received an email and it said that it wants to do this particular thing and they wanted to talk about my work as a diversity advocate. She said, "Oh my gosh, do you know this human trafficking stuff that's going on? What if these people want to take you to Cape Town and they're trying to traffic you?" Literally, that's how farfetched the thought was. We had to do a lot of due diligence to believe it.Where was that shot?It was shot in Cape Town. I actually brought some of my family jewelry that was very Southern African because representation is very multifaceted. Yes, there is the woman with albinism, but there's a Southern African Xhosa woman. There's just all of these facets of identity that have a story to it and I wanted to do my best to bring everybody with me in the best way I could.Related: Ostracized in Tanzania, this community of albinos sing songs of acceptanceSpeaking of identity, I've really been wanting to ask you this question since I learned about your story. South Africa is known for apartheid, a government policy that separated whites from blacks from society for years. What did that do to your own understanding of who you are?That's a very intense question. The interesting thing I've learned is that race is an institution that was bred from a figment of somebody's imagination, but had very real consequences. Consequences that lived beyond color, because I am a black woman that still experiences the consequences of what race is and I don't have the color. But I learned something being in this body. It's that the issue isn't racism, isn't patriarchy and isn't issues with respect to albinism. The issue is that we have a behavioral defect with how we deal with difference.When do you think it won't be a big deal anymore for a person with albinism to be on a cover of Vogue or any fashion magazine? When it's just a model on the cover and she just happens to have albinism?It's a very difficult question to answer because I think right now we're getting to a point where people are celebrating for us quite a lot. You're the first woman to do this, you're the first black person to do that, the first person with albinism to do that, the first otherly-abled person to do this. The more you get frequency of representation, the more you'll be able to normalize something that is considered extraordinary. Probably frequency would help a lot because the frequency would not make it a deviance, it would make it a normalization. We need to start setting values that allow for that kind of progress, diversity and inclusion.This interview has been edited and condensed for clarity.
Reflections offered from HOPA's 2019 annual conference on cabozantinib, regorafenib, low-dose azacitidine, SC granisetron (this is a thing), clinical trial hope, and opportunities for students in HOPA
Revolutionary Grooves irratsaioan, hip-hop eta jazzaren arteko fusioa den trip-hopa musika entzuteko aukera izan dugu. 90.hamarkadako eta gaur egungo artista esanguratsuenak bertan izan dira entzungai: Dj Spinna, Herbaliser, Triky, The Wisseguiss, Rae and Christian, Cinematic Orchestra, Herbie, Could Cut, Ape, Pronoia, Kusti, , Strata 3, Aim, Dan the automator, Houie.B, Sasha, Dr.Octagon, Dj Vadim, Jagga Jazzist...
Dopadła mnie [Macieja, dop. Maciej]. Podstępna, zimna i kolorowa. Jesień bezpardonowo zaatakowała. Na początku ukrywała się za ciepłymi promykami słońca. Obiecywała, że jeszcze będę mógł założyć letnie ubranie i komfortowo spacerować do późna. Dała nadzieję, a ja głupi uwierzyłem. Zgodziłem się na warunki jakie postawiła. I co mam z tego teraz? Zawijam się w kocowe burrito, biorę pada do ręki i próbuje skończyć ten nieszczęsny Bastion. Albo uruchamiam Netflixa i zatapiam się w historie, jakie przygotowali dla nas scenarzyści, reżyserowie, czy animatorzy. Z tego wszystkiego nie skonsumowałem żadnej mądrej rzeczy, która skłoniłaby mnie do głębszych przemyśleń. Jakoś nie mogę zabrać się za czytanie książek, jedyne co daje radę chłonąć, to artykuły z czasopism takich, jak Pixel albo Pismo. Tych znowuż nie ma sensu streszczać, bo same w sobie są na tyle ciekawe, że zachęcam was do odkrywania ich we własnym zakresie (nie, to nie chamska reklama, ja po prostu lubię te czasopisma, prenumeruje je i bez względu na wszystko będę je polecał :P ). Ale, jeśli spodobała wam się moja recenzja gry Machinarium, którą linkowałem tydzień temu, to może spodoba wam się następna. Tiny Bang Story to spokojna i urocza gra HOPA. Spróbujecie i dajcie znać, czy wam się też spodobała :) https://arhn.eu/2015/12/the-tiny-bang-story-recenzja/ Zapraszamy serdecznie do wysłuchania pięćdziesiątego czwartego odcinka podcastu Zaczepieni. Odcinek jest totalnie zdominowany przez Assassin’s Creed: Odyssey, którego obecnie ogrywa Adam. Gra, z opisów grającego, broni się i rzeczywiście wydaje się być najlepszą odsłoną serii od niezapomnianej i kultowej już części drugiej. Oprócz tego sporo newsów i komentarzy do bieżących zdarzeń ze świata popkultury. Bawmy się! UWAGA, sypiemy SPOILER'AMI na lewo i prawo. Nie ma taryfy ulgowej! Dzisiaj rozmawiamy o: - tym, że szef Ubisoft twierdzi, że branży growej brakuje duszy (a przynajmniej powinna jej mocniej szukać) - http://www.gamasutra.com/view/news/327863/Ubisoft_chief_The_games_industry_needs_to_find_its_soul.php - tym, że w 2019 będzie odświeżona wersja Switch - https://www.eurogamer.net/articles/2018-10-04-nintendo-to-launch-updated-switch-next-year-report - tym, że Pokemon Red zostało odtworzone w Minecrafcie - https://arhn.eu/2018/10/pokemon-red-odtworzone-w-minecrafcie/ - tym, że Ktoś robi Baldur’s Gate 3 - http://pixelpost.pl/ktos-robi-baldurs-gate-3/ - tym, że Finałowy sezon The Walking Dead otrzyma zakończenie - http://pixelpost.pl/finalowy-sezon-the-walking-dead-otrzyma-zakonczenie/ - nowym projekcie streamingowym Microsoftu - https://kotaku.com/microsoft-announces-xbox-game-streaming-service-1829595928 - tym, że Banksy zniszczył na aukcji swoją własną pracę wartą 1,4 miliona dolarów - https://sznyt.pl/2018/10/08/banksy-zniszczyl-na-aukcji-swoja-wlasna-prace-warta-14-miliona-dolarow/ - tym, że Irlandia stwierdza że loot boxy są ok - https://www.purepc.pl/prawo_i_gospodarka/irlandia_wycofuje_sie_z_walki_z_loot_boksami_w_grach_wideo - tym, że Techland robi beep - Call of Juarez - https://polygamia.pl/call-of-juarez-cos-ruszylo/ - tym, że Nowe kary AMD są już tuż tuż - https://www.purepc.pl/karty_graficzne/nowe_radeony_moga_byc_juz_bardzo_blisko_debiutu_na_rynku - drugim trailerze do dzikich koni na zachodzie 2 - https://www.youtube.com/watch?v=lb-tlY6ytk8 - pierwszych wrażeniach Adama po zagraniu w AC: Odyssey - https://assassinscreed.ubisoft.com/game/pl-pl/home Miłego słuchania :)
Highlights from last week's HOPA annual conference are discussed, followed by (13:09) a lightning-style run through of #oncopharm updates over the last 2 weeks.
Previewing HOPA18 and its highly anticipated sessions, networking opportunities, and virtual attendance.
Çaykur Boykotunda Öne çıkan Hopa Çay'ı Üreticilerden Dinliyoruz
Niespodzianka! Nie spodziewaliście się dzisiaj odcinka, co? A czy ktoś z was kojarzy Kapryfolium? Jęki Walenia? Nie? Nic? Troszkę? A może Artifex Mundi? Taką dużą, polską firmę produkująca głównie gry HOPA. Wiedziałem, to już kojarzycie. Magdalena Cielecka, aktualnie doktorantka na wydziale Zarządzania i Komunikacji Społecznej UJ, oraz Producentka we wspomnianej wyżej firmie, zgodziła się udzielić nam wywiadu! Jaracie się? My się jaramy :D Mamy nadzieje, że odsłuchanie tego nagrania sprawi wam tyle frajdy, ile nam sprawiło jego nagranie ;) Dzisiaj spojlujemy tylko fakty z życia Magdy, nie ma popkulturowych obaw ;) Miłego Słuchania :)
As B. Dolan and Sage Francis bring their latest Edinburgh Fringe Show Tricknology to an end, I felt it was time to revisit this interview with B. Dolan from back in October 2015. Enjoy.The Curator Podcast – Episode 19: B. DolanAs I get older I find myself growing to appreciate hip hop more and more. In my teens it didn't grab me in the same way punk or metal did, and naively, I shunned it. My guest on this episode is rapper B. Dolan and he, alongside Sage Francis, was one of the artists who forced me to realign my expectations of what hip hop is, was and could be.The truth of the matter is that when your exposure to a particular genre of music comes solely from mainstream sources, it can be quite difficult to find something worthwhile. Like all teenagers, I rebelled, and in doing so I rebelled against the chart and dance music which was common in between my groups of friends in high school and in my neighbourhood. I took solace in the angst of “alternative” music.A lot of that chart music was hip hop and no, it wasn't particularly good hip hop. As someone who had deliberately placed themselves outside of mainstream art, I found that when I looked back in to find some shred of meaning, all I could see were empty messages and a sense of disappointment.That's not to say that it is impossible for popular music to carry a message. Now that I'm older I can see such a view is quite patently nonsense, but in the naivety of youth I certainly felt that.So in my teens, my flirtation and subsequent rejection of hip hop was the result of two things:A) to me, the stuff that was on the radio or on MTV had nothing to say to me. I was looking for something political, something which raged and had teeth. 50 Cent, Ja Rule, Nelly and the other hip hop that circulated when those artists were at their peak, was empty to me.B) I had no one to guide me. It was easy to find people who could introduce me to new rock music. Literally no one I knew had any inkling of hip hop beyond whatever was coming out of the radio that week.For many years I lived my life ignoring hip hop, thinking that it was all violence and misogyny.About ten years ago that changed. A friend opened me up to “underground” hip hop, with Sage Francis at the head it.At the risk of coming across like a snob, I've always found the entry point for hip hop music to be quite high. Perhaps it's because I'm a snotty punk kid at heart – those short, sharp stabs of music are certainly designed to make you think, but the message is fleeting, it's difficult to hold onto before you're off onto the next song. A hip hop record is more layered and more complex, it demands the full investment of your time. It requires repeated listens and time to unfold in your head.But I appreciate them. I enjoy spending time with an album, deciphering lyrics and meanings, getting underneath the complexity of the music and living inside it.Prior to this interview it had been five years since I last saw B. Dolan play. Weirdly it was five years to the exact day, in the exact same venue. In that particular instance he was supporting Sage Francis, an artist who also happened to be responsible for introducing me to B. Dolan on Twitter some years before.Fallen House, Sunken City, which bizarrely only came out five years ago but it somehow feels longer, is an album which pulled me out of a musical slump I'd fallen into. It's an awesome record, and one of my favourites. Although I do think his new one, Kill the Wolf, might usurp that.Highlights include:Getting into fights at the Westmoreland service stationA shout out to Passion of the WeissObession with musicAn almost encyclopedic knowledge of hip hopA little bit of PrinceRecording and producing ‘Kill the Wolf'B. Dolan's evolution as a songwriterB. Dolan is a super nice guy, and to hear him close with The Hunter at the show later that night was a pretty huge deal for me. Also, Buddy Peace absolutely killed it. To see an MC and a DJ w... Our GDPR privacy policy was updated on August 8, 2022. Visit acast.com/privacy for more information.
Salut les Bronzés 2017 n°1, l’émission musicale estivale . album de la semaine : Electric Light Orchestra « Out of blue » setlist :ELO Turn to stoneChristopher Cross All rightAmerica Sister golden hairVan Halen DreamsJoe Bonamassa Mountain climbingFrancois Perusse 2 minutes du peupleSupertramp A soapbox operaELO It's overChicago If you leave me nowTOP RINGARD N°1Pat Benatar Hit me with your shot gunThe Allman Brothers Rambin' manFrancois Perusse 2 minutes du peupleDanny and the juniors At the hopA.Souchon/L.Voulzy Derrière les motsJimi Hendrix & the Experience All along the watchtowerELO Sweet talking womanFrancois Perusse 2 minutes du peupleRingo Starr R U readySting I'm so happy I can't stop cryingClaudia Church The streets of NashvilleBlake Shelton Honey beeKenny Rogers The gamblerHank William Jr Go girl goJon Wolfe Girl like youEddy Mittchell J'aime...j'aime pasFrancois Perusse 2 minutes du peupleELO StarlightRobin Gibb Toys (feat. Barry & Maurice Gibb)Roger Hodgson HungryTOP RINGARD N°2Foo Fighters RunRose Et puis juinFrancois Perusse 2 minutes du peupleELO Mister Blue SkyVéronique Riviere C'est pas sérieuxRenaud FatiguéRichard Marx Right here waitingAmerica Tin manRed Hot Chili Peppers Dark necessitiesFrancois Perusse 2 minutes du peupleELO Big wheelsPrince Raspberry beretMichel Fugain Des rêves et du ventThe Rolling Stones Just a foolKiss I was made for loving youOldelaf Nos jours heureuxELO Wild west hero
Frankly Speaking About Cancer with the Cancer Support Community
Over the years on Frankly Speaking About Cancer, we've interviewed countless physicians, social workers, nurses, oncologists, surgeons, mental health professionals and scientists—to name a few. But, there is one person you encounter during the cancer experience who plays a vital role who we have not yet heard from. That's the oncology pharmacist. On this episode of Frankly Speaking About Cancer we're going to learn more about the role the pharmacist plays in the cancer experience.
Frankly Speaking About Cancer with the Cancer Support Community
As I get older I find myself growing to appreciate hip hop more and more. In my teens it didn't grab me in the same way punk or metal did, and naively, I shunned it. My guest on this episode is rapper B. Dolan and he, alongside Sage Francis, was one of the artists who forced me to realign my expectations of what hip hop is, was and could be.The truth of the matter is that when your exposure to a particular genre of music comes solely from mainstream sources, it can be quite difficult to find something worthwhile. Like all teenagers, I rebelled, and in doing so I rebelled against the chart and dance music which was common in between my groups of friends in high school and in my neighbourhood. I took solace in the angst of “alternative” music.A lot of that chart music was hip hop and no, it wasn't particularly good hip hop. As someone who had deliberately placed themselves outside of mainstream art, I found that when I looked back in to find some shred of meaning, all I could see were empty messages and a sense of disappointment.That's not to say that it is impossible for popular music to carry a message. Now that I'm older I can see such a view is quite patently nonsense, but in the naivety of youth I certainly felt that.So in my teens, my flirtation and subsequent rejection of hip hop was the result of two things:A) to me, the stuff that was on the radio or on MTV had nothing to say to me. I was looking for something political, something which raged and had teeth. 50 Cent, Ja Rule, Nelly and the other hip hop that circulated when those artists were at their peak, was empty to me.B) I had no one to guide me. It was easy to find people who could introduce me to new rock music. Literally no one I knew had any inkling of hip hop beyond whatever was coming out of the radio that week.For many years I lived my life ignoring hip hop, thinking that it was all violence and misogyny.About ten years ago that changed. A friend opened me up to “underground” hip hop, with Sage Francis at the head it.At the risk of coming across like a snob, I've always found the entry point for hip hop music to be quite high. Perhaps it's because I'm a snotty punk kid at heart – those short, sharp stabs of music are certainly designed to make you think, but the message is fleeting, it's difficult to hold onto before you're off onto the next song. A hip hop record is more layered and more complex, it demands the full investment of your time. It requires repeated listens and time to unfold in your head.But I appreciate them. I enjoy spending time with an album, deciphering lyrics and meanings, getting underneath the complexity of the music and living inside it.Prior to this interview it had been five years since I last saw B. Dolan play. Weirdly it was five years to the exact day, in the exact same venue. In that particular instance he was supporting Sage Francis, an artist who also happened to be responsible for introducing me to B. Dolan on Twitter some years before.Fallen House, Sunken City, which bizarrely only came out five years ago but it somehow feels longer, is an album which pulled me out of a musical slump I'd fallen into. It's an awesome record, and one of my favourites. Although I do think his new one, Kill the Wolf, might usurp that.Highlights include:Getting into fights at the Westmoreland service stationA shout out to Passion of the WeissObession with musicAn almost encyclopedic knowledge of hip hopA little bit of PrinceRecording and producing 'Kill the Wolf'B. Dolan's evolution as a songwriterB. Dolan is a super nice guy, and to hear him close with The Hunter at the show later that night was a pretty huge deal for me. Also, Buddy Peace absolutely killed it. To see an MC and a DJ work together to create such a tight live show was amazing. Honestly if you get a chance, you should see him.I hope you enjoy the episode.Featured MusicIntro: Voodoo Puppets – Electric Chair Blues (used under CC licence, you can check it out here).B. Dolan - AlrightB. Dolan - Which Side are You On?You can find 'Alright' on the album Kill the Wolf, which you can find over on Strange Famous Records. I make no claim to the copyright of these tracks.Links You can find B. Dolan on Twitter, Facebook, Bandcamp and his website.The Passion of the Weiss interview can be found here.Thank you!My thanks are eternal to you and everyone else who has listened to the podcast and helped me get it to where it is. If you could take a second to rate and review this podcast on iTunes I'd love you forever and ever.Questions? Feedback?You can do either by dropping a comment in the comment box below.Or you can hit the contact link to show me some love by using the cool email form.Social MediaI'm on a few social media sites, so it'd be pretty handy if you could show me some love over there.Check out the Facebook page.Or you can get me on Twitter.Oh and seriously, rating and reviewing this podcast on iTunes would be amazing. Our GDPR privacy policy was updated on August 8, 2022. Visit acast.com/privacy for more information.
Tohumdan Hasada Ekolojik Yaşam: 28 Ağustos 2015 Hopa'ya bağlanarak, Yeşil Artvin Derneği'nin Yönetim Kurulu Üyesi ve Türkiye Barolar Birliği Çevre ve Kent Hukuku Komisyonu Üyesi Avukat Bedrettin Kalın'la, Artvin'de yaşanan sel felaketini konuştuk.
Ekonomi&Ekoloji: 27 Ağustos 2015 Bu hafta Ekonomi Ekoloji'de Çevre Mühendisleri Odası Başkanı Mert Güvenç'le, Hopa'daki sel felaketini ve Doğu Karadeniz'de şuursuzca devam eden doğa talanını ve kontrolsüz yapılaşmayı konuştuk.
Açık Yeşil 26 Ağustos 2015 Açık Yeşil'de bu hafta, Hopa'da yaşanan ve 10 kişinin hayatını kaybettiği sel felaketini, bu felaketin bölgede süregelen doğa tahribatı ve yanısıra iklim değişikliği ile ilişkisini konuştuk.
20 Ağustos 2014 Açık Yeşil'de bu hafta, nükleersiz Karadeniz için Hopa'dan başlayarak Karadeniz kıyıları boyunca kürek çeken Hüseyin Ürkmez konuğumuzdu.
